Journal of Medicinal Chemistry · 2012 · 30 citations · 41 references
Life SciencesOncologyPharmacologyApoptosisCancer PharmacologyMolecular OncologyEicosanoid BiosynthesisEssential Fatty AcidsFatty Acid ChemistryFatty Acid MetabolismLipid MetabolismCell InvasionCyclooxygenase-2 PathwayDietary Fatty AcidsEicosapentaenoic AcidFatty AcidsOmega-3 Fatty AcidsOmega-6 Fatty AcidsUnsaturated Fatty Acids
Cyclooxygenase-2 (COX-2) is overexpressed in many human cancers and converts the n-6 polyunsaturated fatty acid (PUFA) arachidonic acid to prostaglandin E(2) (PGE(2)), which drives tumorigenesis; in contrast, n-3 PUFA inhibit tumorigenesis. We tested the hypothesis that these antitumor actions of n-3 PUFA may involve the n-3 olefinic bond. n-3 Monounsaturated fatty acids (MUFAs) of chain length C16-C22 were synthesized and evaluated in MDA-MB-468 breast cancer cells that stably overexpressed COX-2 (MDA-COX-2 cells). Longer chain (C19-C22) n-3 MUFAs inhibited proliferation, activated apoptosis, decreased PGE(2) formation, and decreased cell invasion; C16-C18 analogues were less active. Molecular modeling showed that interactions of Arg120, Tyr355, and several hydrophobic amino acid residues in the COX-2 active site with C19-C22 MUFA analogues were favored. Thus, longer-chain n-3 MUFAs may be prototypes of novel anticancer agents that decrease the formation of PGE(2) in tumor cells that contain high levels of COX-2.
41
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents
Ravi G. Kurumbail, Anna M. Stevens, James K. Gierse et al. · Nature · 1996 · 1.9K citations
Aspirin and the Risk of Colorectal Cancer in Women
Edward L. Giovannucci, Kathleen M. Egan, David J. Hunter et al. · New England Journal of Medicine · 1995 · 1.1K citations · Full text
Medicine, Oncology, Pharmacology +12
Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.
Ari Ristimäki, Anna Sivula, Johan Lundin et al. · PubMed · 2002 · 787 citations
Medicine, Cancer Biology, Oncology +16